Bronze partner

genome protection inc

Genome Protection, Inc. (GPI) is a Buffalo, NY-based clinical stage biotechnology company focused on developing systemic medical interventions to prevent and treat aging and age-related diseases.

GPI has established a novel platform for development of antiaging therapies based on counteracting two key potential therapeutic targets: intrinsic mechanisms of DNA damage and immunosenescence.

Our prospective products include: (i) small molecule inhibitors of the polymerase and endonuclease activities of reverse transcriptase of human LINE-1 retrotransposon (RTL1), (ii) immunotherapeutic agents that stimulate immune-mediated destruction of cells with damaged DNA and revert immunosenescence, and (iii) immunodiagnostic of retrobiome activity.